Indonesia Pharmas Seek Government Incentives For Processing APIs
This article was originally published in PharmAsia News
Indonesia's drug makers are pressing the government to give them some financial help to process the nation's abundance of raw materials as a way to reduce dependence on imports.
You may also be interested in...
The US FDA issued only one device-related close-out letter in October.
Seven pharmacies have filed a lawsuit against the FDA claiming the agency exceeded its statutory authority in its final standard memorandum of understanding on interstate compounding and that the MOU will have an adverse impact on compounding pharmacies and patients.
Several experts spoke with Scrip about their take on how the biopharmaceutical industry's efforts to respond to COVID-19 might help industry's image problem.